Skip Navigation

Cardiovascular Research 1998 39(2):393-400; doi:10.1016/S0008-6363(98)00116-3
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Campbell, B.
Right arrow Articles by Lefer, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, B.
Right arrow Articles by Lefer, A. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart1

Barry Campbell, Yong K. Shin, Rosario Scalia and Allan M. Lefer*

Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA

* Corresponding author. Tel.: (215) 503-7760; Fax: (215) 503-2073; E-mail: lefer1@jeflin.tju.edu

Objective: Ischemia followed by reperfusion in the presence of polymorphonuclear leukocytes (PMNs) results in cardiac contractile dysfunction as well as myocardial injury. These deleterious effects are due in large part to endothelial dysfunction leading to an upregulation of cell adhesion molecules and subsequent neutrophil-induced cardiac injury. At physiologically relevant concentrations, N,N,N-trimethylsphingosine (TMS), a synthetic N-methylated sphingosine derivative, has been shown to attenuate leukocyte–endothelial cell interactions. We wanted to test the effects of TMS on neutrophil-mediated cardiac dysfunction in ischemia/reperfusion. Methods: This study examines the effects of TMS in a neutrophil-dependent isolated perfused rat heart model of ischemia (I) (20 min) and reperfusion (R) (45 min) injury. Results: Administration of TMS (20 µg/kg) to I/R hearts perfused with PMNs improved coronary flow and preserved left ventricular developed pressure as an index of cardiac contractile function (95±5%) in comparison to those I/R hearts receiving only vehicle (60±7%) (P<0.001). In addition, TMS significantly reduced PMN accumulation in the ischemic myocardium, as evidenced by an attenuation in cardiac myeloperoxidase activity from 1.12±0.04 in untreated hearts to 0.01±0.02 in treated hearts (P<0.001). However, TMS did not directly stimulate nitric oxide (NO) release from rat vascular endothelium. Conclusion: These results provide evidence that TMS is a potent and effective cardioprotective agent that inhibits leukocyte–endothelial cell interactions and preserves cardiac contractile function and coronary perfusion following myocardial ischemia and reperfusion.

KEYWORDS Neutrophils; Myocardium; Cell adhesion molecules; Sphingosine; Rat; NO electrode

1 Supported in part by Research Grant GM-45434 from the National Institute of General Medical Sciences, NIH.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Vet PatholHome page
A. Ramachandran, S. Jha, and D. J. Lefer
REVIEW Paper: Pathophysiology of Myocardial Reperfusion Injury: The Role of Genetically Engineered Mouse Models
Vet. Pathol., September 1, 2008; 45(5): 698 - 706.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.